Maximizing binding capacity for protein A chromatography.

Area of Science:

• Biotechnology
• Biopharmaceutical Manufacturing
• Protein Chromatography

Background:

• Monoclonal antibody (mAb) production yields have increased significantly, necessitating efficient downstream purification processes.
• High capacity capture steps are essential to avoid purification bottlenecks in biomanufacturing.
• Protein A chromatography is the preferred method for mAb capture due to its high selectivity, despite cost and limitations.

Purpose of the Study:

• To enhance the binding capacity of Protein A chromatography for downstream purification of high-titer monoclonal antibodies.
• To optimize Protein A capture using a novel high-capacity resin and a dual flow loading strategy.
• To evaluate the impact of increased loading on process performance and product quality.

Main Methods:

• A new generation high-capacity Protein A resin was employed.
• A dual flow loading strategy was implemented to maximize resin utilization.
• Empirical Design of Experiments (DOE) was used to establish optimal loading conditions.
• Process performance and product quality were assessed across a panel of antibodies.

Main Results:

• Dynamic binding capacities exceeding 65 g/L were achieved, representing a >1.5-fold increase over traditional methods.
• The dual flow loading strategy maximized binding capacity without substantially increasing processing time.
• Process performance metrics and product quality attributes remained comparable at the elevated loading levels.

Conclusions:

• The optimized Protein A capture process significantly enhances throughput for high-titer mAb production.
• This approach overcomes previous capacity limitations, improving the efficiency of biopharmaceutical manufacturing.
• The method demonstrates scalability and robustness for purifying diverse monoclonal antibodies.